Marksans Pharma Gets USFDA Approval for Generic Allergic Rhinitis Treatment
By Rediff Money Desk, New Delhi Nov 22, 2024 17:30
Marksans Pharma receives USFDA approval for its generic version of Loratadine tablets, a treatment for allergic rhinitis. The approval marks a significant milestone for the company.
New Delhi, Nov 22 (PTI) Marksans Pharma Ltd on Friday said it has received final approval from the US health regulator for its generic version of Loratadine tablets indicated in the treatment of allergic rhinitis.
The approval by the US Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Loratadine tablets of strength 10 mg, Marksans Pharma said in a regulatory filing.
Loratadine tablets are indicated for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use. This product is a generic version of Clartin tablet in the same strength as Bayer Healthcare, the company added.
Loratadine is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies, it added.
The approval by the US Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Loratadine tablets of strength 10 mg, Marksans Pharma said in a regulatory filing.
Loratadine tablets are indicated for the treatment of allergic rhinitis caused by pollen and upper respiratory tract allergy for over-the-counter (OTC) use. This product is a generic version of Clartin tablet in the same strength as Bayer Healthcare, the company added.
Loratadine is an antihistamine that treats symptoms such as itching, runny nose, watery eyes, and sneezing from "hay fever" and other allergies, it added.
Source: PTI
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 7.02 (+ 5.25)
- 54412711
- Srestha Finvest
- 0.61 ( -3.17)
- 29610670
- AvanceTechnologies
- 0.94 (+ 1.08)
- 19664311
- YES Bank Ltd.
- 19.12 ( -0.52)
- 10825002
- Murae Organisor
- 2.20 (+ 19.57)
- 10474390
MORE NEWS
GoM Report on GST on Health Insurance to be...
The GoM report on GST implications for life and health insurance will be presented to...
EPF Inoperative Accounts: Amount Surges to Rs...
The total amount in inoperative EPF accounts has jumped over fivefold to Rs 8,505.23...
Five States Lag in Labour Code Rules...
Five states are yet to pre-publish draft rules on three labour codes, while four states...